Richard P. Slaughter Associates’s ARK Genomic Revolution ETF ARKG Stock Holding History

Richard P. Slaughter Associates’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-59,431	Closed	-$1.87M	–	124
2022 Q2	$1.87M	Sell	59,431 -9,258	-13%	-$324K	0.82%	36
2022 Q1	$3.15M	Buy	68,689 +32,483	+90%	+$1.55M	1.16%	20
2021 Q4	$2.22M	Sell	36,206 -11,374	-24%	-$786K	0.78%	38
2021 Q3	$3.56M	Sell	47,580 -1,623	-3%	-$136K	1.41%	12
2021 Q2	$4.55M	Buy	49,203 +9,794	+25%	+$833K	1.76%	9
2021 Q1	$3.5M	Buy	+39,409	New	+$3.91M	1.45%	19

Other funds holding ARKG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Richard P. Slaughter Associates's ARKG Position: Q3 2022 in Review

Richard P. Slaughter Associates sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2022, closing a stake of 59,431 shares — an estimated $1.87M sold.

Richard P. Slaughter Associates first reported a position in ARKG in Q1 2021 and held it in 6 quarters. The position peaked at $4.55M in Q2 2021. 312 funds tracked by Wall St. Rank hold ARKG as of Q3 2022.

Richard P. Slaughter Associates reported no remaining ARK Genomic Revolution ETF position as of Q3 2022 after selling out during the quarter.
Richard P. Slaughter Associates sold 59,431 ARK Genomic Revolution ETF shares in Q3 2022, an estimated $1.87M.
Richard P. Slaughter Associates first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 6 quarters.
Richard P. Slaughter Associates's ARK Genomic Revolution ETF position peaked at $4.55M in Q2 2021.
312 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2022.

Based on Richard P. Slaughter Associates's 13F filing for Q3 2022, filed 11 Oct 2022.